OR WAIT null SECS
August 03, 2023
The biggest hurdle is developing palatable formulations that are efficacious and patient friendly.
August 01, 2023
In this episode, David Tisi and Reenal Gandhi provide expert insights into advances and innovations changing the drug dosage form landscape.
July 03, 2023
Sample dilution, sensitivity, excipient interference, and containment are key issues that must be addressed.
June 02, 2023
Nanotech-based delivery technologies are receiving significant attention.
May 17, 2023
This deal would help the companies merge to work on future projects and conduct research together.
May 04, 2023
Vibha Jawa, executive director at Bristol Myers Squibb, discusses foreign epitopes recognition from what should be fully human antibody therapies.
May 02, 2023
Process control is essential for using continuous hot-melt extrusion to enhance solubility.
In this episode, Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.
April 15, 2023
Unique solutions are required to protect inherently unstable messenger RNA.
April 03, 2023
Despite the advantages intensified processes can offer developers, there are still some obstacles to overcome before broader application of new technologies will be implemented.